Concentra rebounds from Jounce buy with a shot at COVID-19-focused Atea

Concentra rebounds from Jounce buy with a shot at COVID-19-focused Atea

Source: 
Fierce Biotech
snippet: 

Weeks after closing a deal to buy Jounce Therapeutics, Concentra Biosciences is rebounding to pick up another struggling biotech, this time COVID-19-focused Atea Pharmaceuticals.